Applicant, as named in the Orange Book

Nuvalent

Next listed expiry: Jideytro on 30 Sep 2042. 1 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Jideytro · 2 strengths zidesamtinib	zidesamtinib	220185	30 Sep 2042	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.